Clinical Professor--University of Pennsylvania
Oncology
Dr. Paul S. Wissel, MD
|
|
Give Review
Paul Wissel works in the field of Oncology. He attended Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is one of the top medical schools in the US. Columbia University College of Physicians & Surgeons is ranked 8/52 in Research/PrimaryCare. He received awards:"CMS Meaningful Use Stage 1 Certification". Paul Wissel is a published physician as well. He has 22 publications published. The latest was: Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Population pharmacokinetic and dynamic Analysis of the topoisomerase I inhibitor lurtotecan in phase II studies.
- Androgen antagonists: Potential role in prostate Cancer prevention.
- Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein.
- Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918.
- The development and application of a radioimmunoassay for dihydrodigoxin, a digoxin metabolite.
- The absence of significant Biliary excretion of antipyrine or its metabolites in humans.
- Dietary influences on ethanol metabolism.
- Porphyria cutanea tarda associated with the acquired immune deficiency syndrome.
- Diet-hormone interactions: protein/carbohydrate ratio alters reciprocally the plasma levels of testosterone and cortisol and their respective binding globulins in man.
- A comparison of the effects of a macrobiotic diet and a Western diet on drug metabolism and plasma lipids in man.
- Tin-protoporphyrin inhibits heme oxygenase and prevents the decline in hepatic heme and cytochrome P-450 contents produced in nude mice by tumor transplantation.
- Red blood cell aggregation versus blood clot formation in ionic and nonionic contrast media.
- Dose dependent suppression of hepatic cytochrome P-450 content by doxorubicin and Mitomycin-C: correlation with antipyrine biotransformation.
- The influence of antineoplastic chemotherapy on antipyrine metabolism in man.
- Protective effect of Sn-protoporphyrin against doxorubicin-induced perturbations of heme metabolism.
- A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors.
- A pilot study of edrecolomab (Panorex, 17-1A antibody) and capecitabine in patients with advanced or metastatic adenocarcinoma.
- Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving c...
- Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon Cancer.
- Topotecan therapy in patients with relapsed small-cell lung Cancer and poor performance status.
- Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with ex...
Schools
Columbia University College Of Physicians and Surgeons
Ohio State University College of Medicine
Ohio State University College Of Optometry
Sloan Kettering
Columbia University College of Physicians And Surgeons
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Bile Duct Cancer
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Memorial Sloan-Kettering Cancer Center -
University Hospital - University of Cincinnati College of Medicine -
Ohio State University Hospital -
Columbia University College of Physicians & Surgeons
Hospital
-
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1760426662 | |
| NPPES Provider LastName | WISSEL | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 191045127 | |
| NPPES Provider State | PA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 29.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760426662 |
| Last Name Of The Provider | WISSEL |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Lori A. Goldstein, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lainie Martin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Yanis Boumber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert H. Vonderheide, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Joshua M. Bauml, MD
This Doctor is OpenDoctor Recommended.
|